Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy.

But a new study by Northwestern University's Feinberg School of Medicine shows these drugs, called erythropoiesis-stimulating agents, actually raise patients' risk of death by 10 percent, possibly by stimulating the growth of cancer cells.